(MENAFN- The Peninsula)
Buenos Aires: Arabian horse racing is part of the rich history and culture of Qatar. Maintaining the status as the best Arab horse breeder is a permanent challenge and the Argentine company Kheiron Biotech is emerging as the ideal option to push the limits.
Since 2013, Kheiron Biotech has been a leader in the creation of horse cloning technologies allowing the generation of new offspring that are genetic replicas of the best sporting animals. So far, more than 100 clones have been born with the help of Kheiron's powerful technology.
Daniel Sammartino, the founder of Kheiron Biotech, knows that the winning formula for every great equestrian is to have even greater horses. In this sense, Kheiron's technology has delivered almost unimaginable progress in the world of horse breeding, their results in the field being the most reliable proof.
By 2021, the Argentine laboratory had already generated more than 250 equine clones, testing the most precise breeding process ever developed.
Gene editing combined with cloning technology will expand the potential of equine performance in competing animals and this fits perfectly with Qatar's desire to have the best Arabian horses in the world.
Argentina and the Gulf share a culture and a common history of horse breeding and Kheiron offers the exact solutions for developing the best high performance equine athletes.
Cloning is a perfect combination to conventional breeding and the advanced technology of Kheiron would allow horse racing to make a step further in the quality of the show.
Kheiron is a leader in the experimentation of gene editing. Their advanced technology using mesenchymal cells proved to eliminate health issues with cloned horses almost completely and enables the possibility of improving their muscle strength and endurance.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.